Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma-Reference-Cited by-同舟云学术

Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma

Published:2016-07-22 Issue:11 Volume:29 Page:1433-1442
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Lee Lik Hang,Cavalcanti Marcela S,Segal Neil H,Hechtman Jaclyn F,Weiser Martin R,Smith J Joshua,Garcia-Aguilar Julio,Sadot Eran,Ntiamoah Peter,Markowitz Arnold J,Shike Moshe,Stadler Zsofia K,Vakiani Efsevia,Klimstra David S,Shia Jinru^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2016139.pdf

Reference28 articles.

1. Hamid O, Robert C, Daud A et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013;369:134–144.

2. Herbst RS, Soria JC, Kowanetz M et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014;515:563–567.

3. Powles T, Eder JP, Fine GD et al. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature 2014;515:558–562.

4. Topalian SL, Hodi FS, Brahmer JR et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012;366:2443–2454.

5. Brahmer JR, Tykodi SS, Chow LQM et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012;366:2455–2465.

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study on the prognostic value and clinicopathological significance of different immune checkpoints in patients with colorectal cancer: a systematic review and meta-analysis;Current Therapeutic Research;2024-09

2. Medullary carcinomas of the nonampullary small intestine: association with coeliac disease, mismatch repair deficiency, PD‐L1 expression, and favourable prognosis;Histopathology;2024-08-28

3. The prognostic value of programmed death-ligand 1 (PD-L1) expression in resected colorectal cancer without neoadjuvant therapy - differences between antibody clones and cell types;BMC Cancer;2024-08-26

4. Subclone from CT26 resistant to anti-PD-1 therapy associated with increased expression of genes related to glucocorticoids;Translational Oncology;2024-08

5. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy;Cancers;2024-05-24